The value of 4-month neurocognitive function as an endpoint in brain metastases trials

Journal of Neuro-Oncology

Volumn 120, Issue 2, 2014, Pages 311-319

  Onodera, Shunsuke ^a   Aoyama, Hidefumi ^b   Tha, Khin Khin ^a   Hashimoto, Naoki ^a   Toyomaki, Atsuhito ^a   Terae, Satoshi ^a   Shirato, Hiroki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Brain; Metastasis; Neurocognitive function; Stereotactic radiosurgery; Whole brain radiation therapy

Indexed keywords

ADULT; ARTICLE; ATTENTION; BRAIN EDEMA; BRAIN METASTASIS; BRAIN RADIATION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; HUMAN; JAPAN; LONG TERM MEMORY; MALE; MEMORY DISORDER; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PILOT STUDY; PROSPECTIVE STUDY; RADIOTHERAPY; SHORT TERM MEMORY; STEREOTACTIC RADIOSURGERY; STEREOTACTIC RADIOTHERAPY; STEREOTACTIC TREATMENT; TREATMENT OUTCOME; AGED; BRAIN NEOPLASMS; CANCER GRADING; COGNITION; FOLLOW UP; MEMORY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; PSYCHOLOGY; RADIATION RESPONSE; RADIOSURGERY; SECONDARY; SKULL IRRADIATION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; COGNITION; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEMORY; MIDDLE AGED; NEOPLASM GRADING; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; PROGNOSIS; PROSPECTIVE STUDIES; RADIOSURGERY; YOUNG ADULT;

EID: 84910146765     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1550-y     Document Type: Article

References (29)

1. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G (2006) Stereotactic radiosurgery plus whole-brain radiation therapy versus stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491. doi:10.1001/jama.295.21.2483
2. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037–1044. doi:10.1016/S1470-2045(09)70263-3
3. Tsao M, Xu W, Sahgal A (2011) A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer. doi:10.1002/cncr.26515
4. Sun A, Bae K, Gore EM, Movsas B, Wong SJ, Meyers CA, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H (2011) Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. J Clin Oncol 29:279–286. doi:10.1200/JCO.2010.29.6053
5. Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29:134–141. doi:10.1200/JCO.2010.30.1655
6. Lin NU, Wefel JS, Lee EQ, Schiff D, van den Bent MJ, Soffietti R, Suh JH, Vogelbaum MA, Mehta MP, Dancey J, Linskey ME, Camidge DR, Aoyama H, Brown PD, Chang SM, Kalkanis SN, Barani IJ, Baumert BG, Gaspar LE, Hodi FS, Macdonald DR, Wen PY (2013) Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group. Lancet Oncol 14:e407–e416. doi:10.1016/S1470-2045(13)70308-5
7. Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Mueller RP, Tridello G, Collette L, Bottomley A (2013) A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 31:65–72. doi:10.1200/JCO.2011.41.0639
8. Gold JM, Queern C, Iannone VN, Buchanan RW (1999) Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity. Am J Psychiatry 156:1944–1950
9. Wilde MC (2006) The validity of the repeatable battery of neuropsychological status in acute stroke. Clin Neuropsychol 20:702–715. doi:10.1080/13854040500246901
10. Randolph C, Tierney MC, Mohr E, Chase TN (1998) The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 20:310–319
11. Gontkovsky ST, Mold JW, Beatty WW (2002) Age and educational influences on RBANS index scores in a nondemented geriatric sample. Clin Neuropsychol 16:258–263
12. Strauss E, Sherman EMS, Spreen O (2006) A compendium of neuropsychological tests: administration, norms, and commentary. Oxford University Press, Oxford
13. Hirota C, Watanabe M, Sun W, Tanimoto Y, Kono R, Takasaki K, Kono K (2010) Association between the Trail Making Test and physical performance in elderly Japanese. Geriatr Gerontol Int 10:40–47. doi:10.1111/j.1447-0594.2009.00557.x
14. Yamashima T, Yoshida M, Kumahashi K, Matsui M, Koshino Y, Higashima M, Nagasawa T, Ueki A, Ohtsuka M, Aoki S, Imuro S, Mori N, Takei N, Hoshino R, Minabe Y, Nanba Y, Nanba M, Kira J, Ohyagi Y, Haraoka J, Akimoto J, Miura N, Kimura S, Matsushita M (2002) The Japanese version of RBANS (repeatable battery for the assessment of neuropsychological status). No To Shinkei 54:463–471
15. Abe M, Suzuki K, Okada K, Miura R, Fujii T, Etsurou M, Yamadori A (2004) Normative data on tests for frontal lobe functions: trail making test, verbal fluency, wisconsin card sorting test (Keio version). No To Shinkei 56:567–574
16. Hashimoto R, Meguro K, Lee E, Kasai M, Ishii H, Yamaguchi S (2006) Effect of age and education on the trail making test and determination of normative data for Japanese elderly people: the Tajiri project. Psychiatry Clin Neurosci 60:422–428. doi:10.1111/j.1440-1819.2006.01526.x
17. Matui M (2009) Normative data for the Japanese version of the repeatable battery for the assessment of neuropsychological status (RBANS). J Lib Arts Sci 37:31–53
18. Matsui M, Nagasaki M, Kasai Y (2010) Modified normative data for the Japanese version of the repeatable battery for the assessment of neuropsychological status (2). J Lib Arts Sci 38:87–133
19. Matsui M, Kasai Y, Nagasaki M (2010) Reliability and validity for the Japanese version of the repeatable battery for the assessment of neuropsychological status (RBANS). Toyama Med J 21:31–36
20. Lin NU, Lee EQ, Aoyama H, Barani IJ, Baumert BG, Brown PD, Camidge DR, Chang SM, Dancey J, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Lamborn KR, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wefel JS, Wen PY (2013) Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group. Lancet Oncol 14:e396–e406. doi:10.1016/S1470-2045(13)70311-5
21. Murray KJ, Scott C, Zachariah B, Michalski JM, Demas W, Vora NL, Whitton A, Movsas B (2000) Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the radiation therapy oncology group protocol 91–04. Int J Radiat Oncol Biol Phys 48:59–64
22. Mehta MP, Rodrigus P, Terhaard CH, Rao A, Suh J, Roa W, Souhami L, Bezjak A, Leibenhaut M, Komaki R, Schultz C, Timmerman R, Curran W, Smith J, Phan SC, Miller RA, Renschler MF (2003) Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 21:2529–2536. doi:10.1200/JCO.2003.12.122
23. Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, Kunkler I, Caudrelier JM, Eisenberg PD, Meerwaldt J, Siemers R, Carrie C, Gaspar LE, Curran W, Phan SC, Miller RA, Renschler MF (2004) Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22:157–165. doi:10.1200/JCO.2004.05.128
24. Li J, Bentzen SM, Renschler M, Mehta MP (2007) Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 25:1260–1266. doi:10.1200/JCO.2006.09.2536
25. Welzel G, Fleckenstein K, Schaefer J, Hermann B, Kraus-Tiefenbacher U, Mai SK, Wenz F (2008) Memory function before and after whole brain radiotherapy in patients with and without brain metastases. Int J Radiat Oncol Biol Phys 72:1311–1318. doi:10.1016/j.ijrobp.2008.03.009
26. McDuff SG, Taich ZJ, Lawson JD, Sanghvi P, Wong ET, Barker FG 2nd, Hochberg FH, Loeffler JS, Warnke PC, Murphy KT, Mundt AJ, Carter BS, McDonald CR, Chen CC (2013) Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2013-305166
27. Chapman CH, Nagesh V, Sundgren PC, Buchtel H, Chenevert TL, Junck L, Lawrence TS, Tsien CI, Cao Y (2011) Diffusion tensor imaging of normal-appearing white matter as biomarker for radiation-induced late delayed cognitive decline. Int J Radiat Oncol Biol Phys 82:2033–2040. doi:10.1016/j.ijrobp.2011.01.068
28. Akiyama K, Tanaka R, Sato M, Takeda N (2001) Cognitive dysfunction and histological findings in adult rats one year after whole brain irradiation. Neurol Med Chir (Tokyo) 41:590–598
29. Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, Shioura H, Inomata T, Kunieda E, Hayakawa K, Nakagawa K, Kobashi G, Shirato H (2007) Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68:1388–1395. doi:10.1016/j.ijrobp.2007.03.048